Detection kit and method for Duchenne/Bell muscular dystrophy based on multiple PCR capture technology
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CAPITALBIO GENOMICS
- Publication Date
- 2018-11-09
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of gene sequencing, and in particular relates to a detection kit and a method for Duchenne / Bell muscular dystrophy based on multiplex PCR target sequence capture technology. Background technique
[0002] Duchenne muscular dystrophy is a fatal X-linked recessive genetic disease, which can be divided into pseudohypertrophic muscular dystrophy (Duchenne muscular dystrophy, DMD) according to the degree of progress BMD (Becker muscular dystrophy, BMD), both are allelic clinically heterogeneous diseases. Among them, the main clinical features of DMD are progressive atrophy and weakness of the proximal skeletal muscles of the extremities, pseudohypertrophy of the gastrocnemius muscle of the calf, involving both the respiratory muscles and the myocardium, and some patients are accompanied by mental retardation. Loss of walking ability and death in the 20s occurs in up to 1 in 3500 male live births. Compared with DMD, the ag...